News tagged with huntsman cancer

A new tool to confront lung cancer

Only 15% of patients with squamous cell lung cancer – the second most common lung cancer – survive five years past diagnosis. Little is understood about how the deadly disease arises, preventing development ...

Jun 19, 2014
popularity 5 / 5 (1) | comments 0

Clinical trial delivers good results in leukemia patients

Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...

Nov 30, 2012
popularity not rated yet | comments 0